Skip to main content
PharmAbcine Inc. logo

PharmAbcine Inc. — Investor Relations & Filings

Ticker · 208340 ISIN · KR7208340000 KO Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2023-06-16 Notice of Dividend Amou…
Country KR South Korea
Listing KO 208340

About PharmAbcine Inc.

http://pharmabcine.com/

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Extraordinary General Meeting (EGM). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the procedural steps for the meeting. Given it is a standard regulatory disclosure regarding corporate governance and meeting preparation, it falls under the RNS category.
2023-06-16 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정)(신생혈관성 연령관련 황반변성 환자를 대상으로 PMC-403 단회 및 반복 투여 용량 증량의 안전성 및 내약성을 평가하기 위한 다기관, 공개, 제 1상 임상시험계획 승인)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PharmAbcine) regarding the approval of a Phase 1 clinical trial by the Ministry of Food and Drug Safety. It details the trial's purpose, methodology, and regulatory status. Since it does not fit into specific categories like financial reports, dividends, or shareholder meetings, and is a formal regulatory disclosure of a material business event, it is classified as a Regulatory Filing (RNS).
2023-05-22 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'PharmAbcine' (주식회사 파멥신) covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial information, business overviews, and management disclosures required by the Korean Financial Supervisory Service (FSS) and the Korea Exchange (KRX). This fits the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is a standard regulatory disclosure for insider shareholding changes, which falls under the 'Director's Dealing' category (DIRS) as it details the share ownership status and changes for a company executive (Choi Jun-hee).
2023-03-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is specifically used to report insider transactions or changes in ownership status by company directors and executives. According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2023-03-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding major shareholders and special related parties (in this case, due to the resignation of executives). This type of filing is categorized as a Major Shareholding Notification.
2023-03-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.